Biogen Inc (NASDAQ:BIIB)

406.16
Delayed Data
As of 4:06pm ET
 +9.52 / +2.40%
Today’s Change
223.25
Today|||52-Week Range
468.55
+65.87%
Year-to-Date
2 Large Cap Biotech Stocks Up More Than 25% in the Last Month
12:18pm / StockNews.com - Paid Partner Content
Could Biogen Be a Millionaire-Maker Stock?
Jun 08 / MotleyFool.com - Paid Partner Content
Top-Performing Biotech ETFs of Last Week
11:10am / Zacks.com - Paid Partner Content
Should You Buy Biogen Stock After Its Stunning FDA Win?
Jun 08 / MotleyFool.com - Paid Partner Content
5 Best Leveraged ETFs of Last Week
8:38am / Zacks.com - Paid Partner Content
The stock market after-party is in Europe
Jun 08 / CNN.com - Paid Partner Content
After a 50% Gain, Is It Too Late to Buy Biogen?
Jun 13 / MotleyFool.com - Paid Partner Content
Biogen's New Alzheimer's Drug Will Cost $56,000 Per Year
Jun 07 / MotleyFool.com - Paid Partner Content
Forget Biogen: These 2 Under-the-Radar Biotechs Are Also Celebrating Breakthroughs
Jun 13 / MotleyFool.com - Paid Partner Content
3 Top-Ranked Stocks to Buy Now on the Dip in June
Jun 07 / Zacks.com - Paid Partner Content
How to Buy Biotech Stocks This Summer
Jun 12 / MotleyFool.com - Paid Partner Content
Biogen's Alzheimer Drug Wins FDA Approval
Jun 07 / Zacks.com - Paid Partner Content
Ignore Biogen: 3 Reasons These Stocks Will Be Better Alzheimer's Investments
Jun 11 / MotleyFool.com - Paid Partner Content
6 Million Americans Are Rooting for Monday's Big Stock Market Winner
Jun 07 / MotleyFool.com - Paid Partner Content
Why Biogen, Lilly, and Prothena Stocks Soared This Week
Jun 10 / MotleyFool.com - Paid Partner Content
Why Eli Lilly Stock Soared Today
Jun 07 / MotleyFool.com - Paid Partner Content
US Indexes End Lower Wednesday
Jun 10 / GuruFocus News - Paid Partner Content
Why Cassava Sciences Was Up 15% in May
Jun 07 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Intel, NextEra Energy, PetroChina, Illumina and Biogen
Jun 10 / Zacks.com - Paid Partner Content
Forget Biogen: These 2 Alzheimer's Drug Stocks Could Make You Rich
Jun 07 / MotleyFool.com - Paid Partner Content
Does Eli Lilly Have the Next Big Alzheimer's Drug?
Jun 09 / GuruFocus News - Paid Partner Content
Biogen's Alzheimer's Disease Treatment Earns FDA Approval
Jun 07 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: BIIB's Drug Approval, ALXN Drug Label Expansion & More
Jun 09 / Zacks.com - Paid Partner Content
Why Biogen Stock Is On Fire Today
Jun 07 / MotleyFool.com - Paid Partner Content
Top Research Reports for Intel, NextEra Energy & PetroChina
Jun 09 / Zacks.com - Paid Partner Content
Stock Market News for Jun 7, 2021
Jun 07 / Zacks.com - Paid Partner Content
Biogen Sinks Despite Raft of Analyst Upgrades
Jun 08 / MotleyFool.com - Paid Partner Content
Biogen Inc. (BIIB) Stock Jumps 5%: Will It Continue to Soar?
Jun 07 / Zacks.com - Paid Partner Content
Senator Takes Aim at Biogen's New Alzheimer's Drug
Jun 08 / MotleyFool.com - Paid Partner Content
AbbVie's (ABBV) Skyrizi Succeeds in Crohn's Maintenance Study
Jun 03 / Zacks.com - Paid Partner Content
Biogen (BIIB) Up as FDA Approves Alzheimer'S Drug Aducanumab
Jun 08 / Zacks.com - Paid Partner Content
Here's the Biggest Challenge Biogen Will Face if Its Alzheimer's Drug Is Approved
Jun 02 / MotleyFool.com - Paid Partner Content
Biotech ETFs Surge on Biogen's Alzheimer Drug Approval
Jun 08 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: MRNA COVID-19 Vaccine Update, Drug Approvals for ALKS, MYOV & More
Jun 02 / Zacks.com - Paid Partner Content
3 Drug Stocks Rise as FDA Okays Biogen Alzheimer's Drug
Jun 08 / Zacks.com - Paid Partner Content
3 Biotech Stocks With Huge Catalysts in June
Jun 02 / MotleyFool.com - Paid Partner Content
Company News for Jun 8, 2021
Jun 08 / Zacks.com - Paid Partner Content
Will This Big Decision Knock the Biogen Roller Coaster Off the Tracks?
Jun 02 / MotleyFool.com - Paid Partner Content
US Stocks Closed With Mixed Returns on Monday
Jun 08 / GuruFocus News - Paid Partner Content